(Q45853121)

16 December 2017

title

Treatment of hepatitis B virus-associated membranous nephropathy with adenine arabinoside and thymic extract (English)

1 reference

16 December 2017

1 reference

Lin CY

1

1 reference

16 December 2017

Lo SC

series ordinal

2

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 February 1991

1 reference

16 December 2017

published in

Kidney International

1 reference

16 December 2017

volume

39

1 reference

16 December 2017

issue

2

1 reference

16 December 2017

page(s)

301-306

1 reference

16 December 2017

https://scigraph.springernature.com/pub.10.1038/ki.1991.37

exact match

0 references

cites work

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

Association of human hepatocellular carcinoma and cirrhosis with hepatitis B virus surface and core antigens in the liver

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

Mechanisms of liver cell injury in acute and chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

Hepatitis B virus DNA in liver and white blood cells of patients with hepatoma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

Detection of hepatitis B virus DNA in mononuclear blood cells.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

Hepatitis B virus DNA in mononuclear cells and analysis of cell subsets for the presence of replicative intermediates of viral DNA.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

Urinary neopterin as a new biochemical marker for the monitoring of disease activity and prognosis in membranous nephropathy associated with hepatitis B surface antigenemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

Hepatitis B virus-associated membraneous nephropathy: clinical features, immunological profiles and outcome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

The detection of HBV-DNA in serum by molecular hybridisation: a more sensitive method for the detection of complete HBV particles

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: comparison with results for other viral markers.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

Detection of HBV infectivity by spot hybridization in HBeAg-negative chronic carriers: HBV DNA in sera from asymptomatic and symptomatic subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

Deposition of hepatitis B e antigen in membranous glomerulonephritis: identification by F(ab')2 fragments of monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

Detection of specific sequences among DNA fragments separated by gel electrophoresis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

Characterization of restriction endonuclease maps of hepatitis B viral DNAs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

Enhancement of interleukin-2 and gamma-interferon production in vitro on cord blood lymphocytes and in vivo on primary cellular immunodeficiency patients with thymic extract (thymostimulin).

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

Preliminary observation of hepatitis B-associated membranous glomerulonephritis treated with leukocyte interferon

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

Hepatitis B virus replication in acute glomerulonephritis with chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.37

7 January 2021

Identifiers

DOI

10.1038/KI.1991.37

1 reference

16 December 2017

Dimensions Publication ID

1013305533

0 references

1 reference

16 December 2017